Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Stussi

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Haematologica|October 12, 2010
Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantationRegula J Mueller, Georg Stussi, Gisella Puga Yung, et al.
Swiss Medical Weekly|June 2, 2011
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experiencePanagiotis Samaras, Marcel Blickenstorfer, Sarah R Haile, et al.
Cancer Epidemiology|December 10, 2017
Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013Annatina Schnegg-Kaufmann, Anita Feller, Helen Baldomero, et al.
Annals of Hematology|August 14, 2010
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastimPanagiotis Samaras, Marcel Blickenstorfer, Raffaele Daniele Siciliano, et al.
Oncology|November 17, 2010
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantationPanagiotis Samaras, Elefteri M Buset, Raffaele Daniele Siciliano, et al.
Blood|February 26, 2025
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trialAdalgisa Condoluci, Ilaria Romano, Daniel Dietrich, et al.
Swiss Medical Weekly|February 28, 2013
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countriesJakob R Passweg, Helen Baldomero, Mario Bargetzi, et al.
Journal of Thrombosis and Thrombolysis|August 18, 2020
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxisChiara Kessler, Hans Stricker, Daniela Demundo, et al.
JAMA|October 2, 2025
Respiratory Syncytial Virus Vaccination in Adult Allogeneic Hematopoietic Cell Transplant RecipientsJonas Lötscher, Carla Simone Walti, Stefanie Heller, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2023
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosisFrancesco Marchi, Chiara Kessler, Daniela Distefano, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Haematologica|October 12, 2010
Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantationRegula J Mueller, Georg Stussi, Gisella Puga Yung, et al.
Swiss Medical Weekly|June 2, 2011
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experiencePanagiotis Samaras, Marcel Blickenstorfer, Sarah R Haile, et al.
Cancer Epidemiology|December 10, 2017
Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013Annatina Schnegg-Kaufmann, Anita Feller, Helen Baldomero, et al.
Annals of Hematology|August 14, 2010
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastimPanagiotis Samaras, Marcel Blickenstorfer, Raffaele Daniele Siciliano, et al.
Oncology|November 17, 2010
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantationPanagiotis Samaras, Elefteri M Buset, Raffaele Daniele Siciliano, et al.
Blood|February 26, 2025
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trialAdalgisa Condoluci, Ilaria Romano, Daniel Dietrich, et al.
Swiss Medical Weekly|February 28, 2013
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countriesJakob R Passweg, Helen Baldomero, Mario Bargetzi, et al.
Journal of Thrombosis and Thrombolysis|August 18, 2020
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxisChiara Kessler, Hans Stricker, Daniela Demundo, et al.
JAMA|October 2, 2025
Respiratory Syncytial Virus Vaccination in Adult Allogeneic Hematopoietic Cell Transplant RecipientsJonas Lötscher, Carla Simone Walti, Stefanie Heller, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2023
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosisFrancesco Marchi, Chiara Kessler, Daniela Distefano, et al.
Pageof 9